Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study.

Almalag, Haya M; Alaujan, Shiekha S; Alhazzani, Hawazin S; Alzamel, Lamia A; Tashkandi, Reem S; Alarfaj, Hussain F; Alarfaj, Abdurhman S; Omair, Mohammed A

Almalag, Haya M; Alaujan, Shiekha S; Alhazzani, Hawazin S; Alzamel, Lamia A; Tashkandi, Reem S; Alarfaj, Hussain F; Alarfaj, Abdurhman S; Omair, Mohammed A.

Affiliation

Almalag HM; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alaujan SS; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alhazzani HS; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alzamel LA; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Tashkandi RS; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alarfaj HF; Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alarfaj AS; Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia.
Omair MA; Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia.

Saudi Pharm J ; 30(7): 1044-1051, 2022 Jul.

Article in En | MEDLINE | ID: mdl-35903531

Key words

Adverse drug reactions; Intravenous biologics; Naranjo scale; Rheumatoid arthritis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Saudi Pharm J Year: 2022 Document type: Article Affiliation country: Saudi Arabia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google